Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

MD‐1 Deficiency Mitigates Atherosclerosis by Inhibiting NLRP3 Inflammasome Activation via cGAS‐STING Dependent Pathway in Macrophages

Findings reveal that MD‐1 promotes pro‐inflammatory (M1‐like) macrophage polarisation in atherosclerosis by inhibiting NLRP3 inflammasome activation via a cGAS‐STING dependent pathway and suggest that MD‐1 neutralisation could be a potential therapeutic strategy for atherosclerosis management.

Fang Zhao, Zhi-Li Jin, Zhi-Wei Cai et al. · 0 citations
Open access Aug 2026

PLCE1 exacerbates the development of atherosclerosis by driving endothelial dysfunction and macrophage inflammation via targeting CTNNB1

The infiltration of macrophages and the inflammatory response they mediate, which are initiated by endothelial dysfunction, are pivotal in both the initiation and progression of atherogenesis. Phospholipase C epsilon 1 (PLCE1) is significantly involved in cardiovascular diseases, in part due to its regulation of va...

Wen-Lin Cheng, Yu-Fang Shi, Quan Zhang et al. · 0 citations
Jul 2026

miR487a-3p and miR6855-3p Facilitate Macrophage Proinflammatory Polarization and Lipid Accumulation in Atherosclerosis.

It is shown that elevated miR487a-3p or miR6855-3p promoted macrophage proinflammatory responses, lipid metabolic dysregulation, and foam cell formation and fulfill the criteria of promising biomarkers for CAD diagnosis and prognosis.

Hai-Jing Ge, Duo Xu, Tao He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.